According to a report published by Allied Market Research, the global Extracorporeal Membrane Oxygenation (ECMO) market is witnessing steady growth due to increasing demand for advanced life-support systems in critical care. The market was valued at $527.5 million in 2023 and is projected to reach $952.2 million by 2035, growing at a CAGR of 5% from 2024 to 2035. Rising prevalence of severe respiratory and cardiac disorders along with technological advancements in extracorporeal life support devices are key factors supporting the expansion of the market worldwide.
Market Snapshot –
• Market Value (2023): $527.5 Million
• Forecast (2035): $952.2 Million
• CAGR: 5%
• Forecast Period: 2024–2035
► Download The Full PDF Report Now:
https://www.alliedmarketresearch.com/request-sample/A08108
Market Introduction
ECMO is a life-saving technique that temporarily replaces heart and lung function by oxygenating blood outside the body. The extracorporeal membrane oxygenation (ECMO) market is expanding due to rise in incidence of respiratory and cardiac failures, advancements in life-support technology, and increase in adoption in critical care. Key developments include innovations in portable ECMO systems, improved biocompatible materials, and increasing government investments in critical care infrastructure. Notable events, such as FDA approvals for ECMO devices and rise in clinical trials to enhance efficiency, are further driving the market growth and adoption in healthcare settings.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Thailand, Malaysia, Indonesia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Argentina, and the rest of LAMEA).
- By component, the oxygenator segment dominated the global extracorporeal membrane oxygenation market in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
- By modulation, the veno arterial segment dominated the global extracorporeal membrane oxygenation market in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
- By application, the respiratory disorders segment dominated the global extracorporeal membrane oxygenation market in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
- By patient type, the adult segment dominated the global extracorporeal membrane oxygenation market in 2023 and is anticipated to be the fastest-growing segment during the forecast period.
- Region-wise, North America dominated the market in terms of revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
★ Request Pricing & Licensing Details @
https://www.alliedmarketresearch.com/purchase-enquiry/A08108
Market Growth & Opportunities Factors:
The extracorporeal membrane oxygenation (ECMO) market is experiencing significant growth, driven by increase in cases of respiratory and cardiac failure, technological advancements, and rise in adoption in intensive care units. Rise in prevalence of conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, and neonatal respiratory failure, drives the growth of the market. For instance, rise in incidence of chronic obstructive pulmonary disease (COPD) led to increased demand for ECMO as a last-resort life-support system. Also, technological advancements, including portable and user-friendly ECMO systems, are enhancing patient outcomes and making the technology more accessible.
Regional Insights
North America dominated the extracorporeal membrane oxygenation (ECMO) market in 2023 owing to advanced healthcare infrastructure, high adoption rates of ECMO systems, and significant government funding. The U.S. leads the region, driven by rise in prevalence of respiratory and cardiac conditions, along with strong support from regulatory bodies such as the FDA. Increased investments in research and development have led to technological advancements, including portable ECMO systems and improved patient monitoring features. For instance, in April 2023, Abbott announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system. With the new indication, the CentriMag Blood Pump for use with the CentriMag System, is now cleared for longer-term use in adults when extracorporeal membrane oxygenation (ECMO. However, challenges such as high treatment costs and limited ECMO-trained specialists exist which may limit market growth.
Europe holds a significant share of the ECMO market, driven by strong healthcare policies, growing ECMO centers, and increasing incidence of chronic respiratory diseases. Countries such as Germany, France, and the UK are at the forefront due to well-established extracorporeal life support (ECLS) programs and government-backed research initiatives. However, strict regulatory approvals and high costs remain key challenges. On the other hand, European nations are investing in public healthcare funding and encouraging local ECMO manufacturing to reduce dependency on imports which provides opportunity for market growth.
Buy Now:
https://www.alliedmarketresearch.com/checkout-final/a54edbf25a191b16fcf192b76bf19f0b
Major Key Players –
- Chalice Medical Ltd.,
- MicroPort Scientific Corporation,
- Terumo Corporation,
- Fresenius SE & Co. KGaA,
- Medtronic plc,
- Abbott Laboratories,
- Eurosets,
- Getinge,
- CytoSorbents Corporation,
- LivaNova PLC
Frequently Asked Questions?
About Us
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.
Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
